FAM55A Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, LY294002 can lead to the inhibition of the PI3K/AKT signaling pathway. Since FAM55A is implicated in cell signaling, inhibiting PI3K can prevent AKT activation, which in turn could prevent any downstream signaling required for FAM55A functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is upstream of ERK in the MAPK pathway. FAM55A's activity could be indirectly inhibited if ERK signaling is reduced, as this pathway is often involved in the regulation of various cellular activities that FAM55A may influence. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, SB203580 can prevent the activation of p38 MAPK, which is involved in inflammatory responses and stress-induced signaling. If FAM55A is responsive to these stimuli, inhibiting p38 MAPK can lead to reduced FAM55A signaling activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, another MAPK pathway component. FAM55A, if it interacts with JNK-dependent signaling pathways, would have decreased activity as a result of JNK inhibition, which could block stress and apoptosis-related signaling events. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, wortmannin can lead to inhibition of the PI3K/AKT pathway similar to LY294002. By inhibiting PI3K, it can prevent downstream effects that may include the functional activity of FAM55A. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin inhibits the mTORC1 complex, which is downstream of PI3K/AKT signaling. Given that mTOR is involved in cellular growth and proliferation, FAM55A's role in these processes could be indirectly inhibited through mTOR inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A Src family kinase inhibitor, PP2 can inhibit signaling pathways that involve Src kinases. If FAM55A is part of signaling cascades that involve Src kinase activity, its functional activity could be indirectly diminished by PP2. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another ERK pathway inhibitor, U0126 specifically inhibits MEK1/2, blocking ERK1/2 activation. This could lead to the inhibition of cellular processes that involve FAM55A if it is regulated by ERK signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
An inhibitor of protein kinase C (PKC), GF109203X could indirectly inhibit FAM55A's function by blocking PKC-mediated signaling pathways, which are involved in various cellular responses. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad tyrosine kinase inhibitor, dasatinib can inhibit multiple kinases, potentially reducing the activity of pathways where FAM55A is relevant, particularly if tyrosine phosphorylation is involved in FAM55A's function. | ||||||